MK-886

From WikiMD's Wellness Encyclopedia

MK-886 is a drug that was initially developed as a leukotriene antagonist but was later found to have other modes of action. It is a potent and selective inhibitor of 5-lipoxygenase activating protein (FLAP), which is involved in the synthesis of leukotrienes. MK-886 also inhibits the peroxisome proliferator-activated receptor alpha (PPARα), a key regulator of lipid metabolism and inflammation.

History[edit | edit source]

MK-886 was first synthesized by Merck & Co. in the 1980s as a potential treatment for asthma and inflammatory diseases. However, clinical trials were discontinued due to the occurrence of side effects such as flu-like symptoms and elevated liver enzymes.

Mechanism of action[edit | edit source]

MK-886 inhibits the 5-lipoxygenase activating protein (FLAP), which is involved in the synthesis of leukotrienes. Leukotrienes are inflammatory mediators that can cause bronchoconstriction and increase mucus production in the lungs. By inhibiting FLAP, MK-886 reduces the production of leukotrienes, thereby potentially reducing inflammation and symptoms of asthma.

In addition to its effects on FLAP, MK-886 also inhibits the peroxisome proliferator-activated receptor alpha (PPARα). PPARα is a nuclear receptor that regulates the expression of genes involved in lipid metabolism and inflammation. Inhibition of PPARα by MK-886 may therefore have effects on lipid metabolism and inflammation.

Clinical significance[edit | edit source]

Despite the discontinuation of clinical trials, MK-886 has been widely used in preclinical research to study the role of leukotrienes and PPARα in various diseases. It has been used in studies of asthma, allergic rhinitis, atherosclerosis, cancer, and other conditions.

See also[edit | edit source]

MK-886 Resources
Wikipedia
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD